Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stassinopoulos

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|December 29, 2006
Functionalized ZnO nanoparticles with liquidlike behavior and their photoluminescence propertiesAthanasios B Bourlinos, Andreas Stassinopoulos, Demetrios Anglos, et al.
The Journal of Infectious Diseases|November 17, 2006
Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplificationJean-Pierre Allain, Jocelyn Hsu, Manisha Pranmeth, et al.
The American Surgeon|March 26, 2022
Evaluation of the Nelson Criteria as an Indicator for Nonsurgical Admission in Trauma PatientsJanet S Lee, Abid D Khan, Lisa Schlitzkus, et al.
Stereotactic and Functional Neurosurgery|June 15, 2000
Multimodality stereotactic brain tissue identification: the NASA smart probe projectR Andrews, R Mah, A Aghevli, et al.
Optics Express|July 9, 2008
Longitudinal coherence of organic-based microcavity lasersAndrea Camposeo, Luana Persano, Pompilio Del Carro, et al.
Transfusion|March 5, 2020
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technologyCissé Sow, Andrew Laughhunn, Yvette A Girard, et al.
Vox Sanguinis|July 13, 2019
Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion modelSherrill J Slichter, S Lawrence Bailey, Irena Gettinger, et al.
Vox Sanguinis|May 18, 2016
Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivationS J Wagner, R J Benjamin, C A Hapip, et al.
Transfusion|October 9, 2015
Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNASonia Bakkour, Daniel M Chafets, Li Wen, et al.
Transfusion|May 20, 2015
Cost implications of implementation of pathogen-inactivated plateletsJeffrey McCullough, Dennis Goldfinger, Jed Gorlin, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Small (Weinheim an Der Bergstrasse, Germany)|December 29, 2006
Functionalized ZnO nanoparticles with liquidlike behavior and their photoluminescence propertiesAthanasios B Bourlinos, Andreas Stassinopoulos, Demetrios Anglos, et al.
The Journal of Infectious Diseases|November 17, 2006
Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplificationJean-Pierre Allain, Jocelyn Hsu, Manisha Pranmeth, et al.
The American Surgeon|March 26, 2022
Evaluation of the Nelson Criteria as an Indicator for Nonsurgical Admission in Trauma PatientsJanet S Lee, Abid D Khan, Lisa Schlitzkus, et al.
Stereotactic and Functional Neurosurgery|June 15, 2000
Multimodality stereotactic brain tissue identification: the NASA smart probe projectR Andrews, R Mah, A Aghevli, et al.
Optics Express|July 9, 2008
Longitudinal coherence of organic-based microcavity lasersAndrea Camposeo, Luana Persano, Pompilio Del Carro, et al.
Transfusion|March 5, 2020
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technologyCissé Sow, Andrew Laughhunn, Yvette A Girard, et al.
Vox Sanguinis|July 13, 2019
Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion modelSherrill J Slichter, S Lawrence Bailey, Irena Gettinger, et al.
Vox Sanguinis|May 18, 2016
Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivationS J Wagner, R J Benjamin, C A Hapip, et al.
Transfusion|October 9, 2015
Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNASonia Bakkour, Daniel M Chafets, Li Wen, et al.
Transfusion|May 20, 2015
Cost implications of implementation of pathogen-inactivated plateletsJeffrey McCullough, Dennis Goldfinger, Jed Gorlin, et al.
Pageof 7